Cargando…
Reducing antipsychotic drugs in stable patients with chronic schizophrenia or schizoaffective disorder: a randomized controlled pilot trial
As the course of schizophrenic disorders is often chronic, treatment guidelines recommend continuous maintenance treatment to prevent relapses, but antipsychotic drugs can cause many side effects. It, therefore, seems reasonable to try to reduce doses in stable phases of the illness or even try to s...
Autores principales: | Huhn, Maximilian, Leucht, Claudia, Rothe, Philipp, Dold, Markus, Heres, Stephan, Bornschein, Susanne, Schneider-Axmann, Thomas, Hasan, Alkomiet, Leucht, Stefan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7960583/ https://www.ncbi.nlm.nih.gov/pubmed/32062728 http://dx.doi.org/10.1007/s00406-020-01109-y |
Ejemplares similares
-
Effects of antipsychotics on heart rate in treatment of schizophrenia: a systematic review and meta-analysis
por: Huhn, Maximilian, et al.
Publicado: (2022) -
Should ‘typical’, first-generation antipsychotics no longer be generally used in the treatment of schizophrenia?
por: Leucht, Stefan, et al.
Publicado: (2021) -
T216. VARIATION IN SIDE EFFECTS TO ANTIPSYCHOTIC TREATMENT ACROSS SCHIZOPHRENIA SPECTRUM DISORDERS
por: Susanne Neumeier, Maria, et al.
Publicado: (2020) -
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
por: Schreyer, Korbinian Felix, et al.
Publicado: (2023) -
Add-on spironolactone as antagonist of the NRG1-ERBB4 signaling pathway for the treatment of schizophrenia: Study design and methodology of a multicenter randomized, placebo-controlled trial
por: Hasan, Alkomiet, et al.
Publicado: (2020)